CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to GSK

Herpes simplex candidate vaccine- adjuvanted GSK 208141

Phase 3
GSK plc (GSK)

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Prophylaxis for Herpes Simplex

View Full Landscape
Drug Information

Target Indication

Prophylaxis for Herpes Simplex

Clinical Trial

NCT00698568

Last updated: 2/5/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.